Adenosine and 2′-deoxyadenosine modified with boron cluster pharmacophores as new classes of human blood platelet function modulators

ChemMedChem

Volumn 5, Issue 5, 2010, Pages 749-756

  Bednarska, Katarzyna ^a   Olejniczak, Agnieszka B ^a   Wojtczak, Błazej A ^a   Sułowska, Zofia ^a   Leśnikowski, Zbigniew J ^a  

^a INSTITUTE OF MEDICAL BIOLOGY   (Poland)

Author keywords

Aggregation; Blood platelets; Boranes; Conjugates; Nucleosides

Indexed keywords

2' O [(4 CARBORAN 1 YL)PROPYLENEOXYMETHYL]ADENOSINE; 6 N (3 OXAPENTOXY) 7,8 ADENOSINE; 6 N [5 [3 COBALT BIS(1,2 DICARBOLLIDE) 8 YL] 3 OXAPENTOXY] 2' DEOXYADENOSINE; 8 (2 4 CARBORANETHYNYL) 2' DEOXYADENOSINE; ADENOSINE DERIVATIVE; ADENOSINE DIPHOSPHATE; BORON; DEOXYADENOSINE DERIVATIVE; PADGEM PROTEIN; THROMBIN; UNCLASSIFIED DRUG; 2'-DEOXYADENOSINE; ADENOSINE; DEOXYADENOSINE; DRUG DERIVATIVE; FIBRINOLYTIC AGENT;

ARTICLE; CHEMISTRY; CONTROLLED STUDY; DRUG EFFECT; DRUG SYNTHESIS; HUMAN; HUMAN CELL; PHARMACOPHORE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE FUNCTION; BLOOD CLOTTING PARAMETERS; METABOLISM; SYNTHESIS; THROMBOCYTE; THROMBOCYTE AGGREGATION;

ADENOSINE; BLOOD PLATELETS; BORON; DEOXYADENOSINES; FIBRINOLYTIC AGENTS; HUMANS; P-SELECTIN; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; THROMBIN;

EID: 77951691338     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.201000075     Document Type: Article

References (39)

1. S. Zalavary, T. Bengtsson, Eur. J. Pharmacol. 1998, 354, 215-225.
2. G. Haskó, B. N. Cronstein, Trends Immunol. 2004, 25, 33-39.
3. B. N. Cronstein, J. Appl. Physiol. 1994, 76, 5-13.
4. G. Anfossi, I. Russo, P. Massucco, L. Mattiello, F. Cavalot, A. Balbo, M. Trovati, Thromb. Res. 2002, 105, 71-78.
5. S. M. Hourani, J. Auton. Pharmacol. 1996, 16, 349-352.
6. A. Edlund, A. Siden, A. Sollevi, Thromb. Res. 1987, 45, 183-190.
7. S. Gessi, K. Varani, S. Merighi, E. Ongini, P. A. Borea, Br. J. Pharmacol. 2000, 129, 2-11.
8. M. J. L. Bours, E. L. R. Swennen, F. Di Virgilio, B. N. Cronstein, P. C. Dagnelie, Pharmacol. Ther. 2006, 112, 358-404.
9. S. A. Poulsen, R. J. Quinn, Bioorg. Med. Chem. 1998, 6, 619-641.
10. K. A. Jacobson, Z. G. Gao, Nat. Rev. Drug Discovery 2006, 5, 247-264.
11. S. W. Ely, R. M. Berne, Circulation 1992, 85, 893-904.
12. M. Kitakaze, M. Hori, T. Kamada, Cardiovasc. Res. 1993, 27, 18-27.
13. L. Willems, K. J. Ashton, J. P. Headrick, Cardiovasc. Res. 2005, 66, 245-255.
14. P. Fishman, S. Bar-Yehuda, L. Madi, I. Cohn, Anti-Cancer Drugs 2002, 13, 437-443.
15. Y. Honma, N. Niitsu, Leuk. Lymphoma 2000, 39, 57-66.
16. J. Z. Wu, C. C. Lin, Z. Hong, J. Antimicrob. Chemother. 2003, 52, 543-546.
17. Y. H. Koh, J. H. Shim, J. Z. Wu, W. Zhong, Z. Hong, J. L. Girardet, J. Med. Chem. 2005, 48, 2867-2875.
18. Z. G. Gao, L. K. Mamedova, P. Chen, K. Jacobson, Biochem. Pharm. 2004, 68, 1985-1993.
19. R. Mathieu, A. Baurand, M. Schmitt, C. Gachet, J. J. Bourguignon, Bioorg. Med. Chem. 2004, 12, 1769-1779.
20. G. Cristalli, C. Lambertucci, S. Taffi, S. Vittori, R. Volpini, Curr. Appl. Phys. Curr. Topic Med. Chem. 2003, 3, 387-401.
21. B. B. Fredholm, R. A. Cunha, P. Svenningsson, Current Topics Med. Chem. 2003, 3, 413-426.
22. Chem. Rev. 1992, 92, 175-364: March special issue on boranes and heteroboranes.
23. R. N. Grimes, Coord. Chem. Rev. 2000, 200-202, 773-811.
24. K. Yamamoto, Y. Endo, Bioorg. Med. Chem. Lett. 2001, 11, 2389-2392.
25. Z. J. Leśnikowski, Collect. Czech. Chem. Commun. 2007, 72, 1646-1658.
26. S. Sjöberg, J. Carlsson, H. Ghaneolhosseini, L. Gedda, T. Hartman, J. Malmquist, C. Naeslund, P. Olsson, W. Tjarks, J. Neuro-Oncol. 1997, 33, 41-52.
27. J. F. Valliant, K. J. Guenther, A. S. King, P. Morel, P. Schaffer, O. O. Sogbein, K. A. Stephenson, Coord. Chem. Rev. 2002, 232, 173-230.
28. B. Wojtczak, A. Semenyuk, A. B. Olejniczak, M. Kwiatkowski, Z. J. Leśnikowski, Tetrahedron Lett. 2005, 46, 3969-3972.
29. A. B. Olejniczak, J. Plesek, Z. J. Leśnikowski, Chem. Eur. J. 2007, 13, 311-318.
30. B. A. Wojtczak, A. B. Olejniczak, Z. J. Leśnikowski, "Nucleoside Modification with Boron Clusters and Their Metal Complexes" in Current Protocols in Nucleic Acid Chemistry, (Ed: S. L. Beaucage), John Wiley & Sons, Inc., Hoboken, 2009, Ch. 4, Unit 4.37, pp. 1-26.
31. K. K. Ogilvie, Can. J. Chem. 1973, 51, 3799-3807.
32. A. B. Olejniczak, B. Wojtczak, Z. J. Leśnikowski, Nucleosides Nucleotides Nucleic Acids 2007, 26, 1611-1613.
33. M. Ikehara, M. Kaneko, Chem. Pharm. Bull. 1970, 18, 2441-2446.
34. W. Jiang, C. B. Knobler, C. E. Curtis, M. D. Mortimer, M. F. Hawthorne, Inorg. Chem. 1995, 34, 3491-3498.
35. S. Kamath, A. D. Blann, G. Y. H. Lip, Eur. Heart J. 2001, 22, 1561-1571.
36. P. Franchetti, L. Cappellacci, S. Marchetti, L. Trincavelli, C. Martini, M. R. Mazzoni, A. Lucacchini, M. Grifantini, J. Med. Chem. 1998, 41, 1708-1715.
37. J. F. Mustard, R. L. Kinlough-Rathbone, M. A. Packham, Methods Enzymol. 1989, 169, 3-11.
38. B. Walkowiak, E. Michalak, W. Koziolkiewicz, C. S. Cierniewski, Thromb. Res. 1989, 56, 763-766.
39. B. Bednar, C. Condra, R. J. Gould, T. M. Connolly, Thromb. Res. 1995, 77, 453-463.